expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology TodayRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)
TRT WorldVečer
العين الإخبارية 
Toi StaffEmanuel FabianAgenciesJacob MagidLuke Tress
Andrew Mitrovica
Gideon LevyYoel ElizurThe Japan News EditorialLazar BermanJessica Steinberg
Belen FernandezMathematicians Against The Genocide In GazaSam SokolReuters
Tarik Cyril Amar
Dr Ramzy BaroudJulian RyallAndrew Lapin
Rachel MarsdenSue SurkesGianluca PacchianiNaomi ConradIlan KapoorThe Asahi ShimbunMurali KrishnanRalf BosenEsraa Abo QamarAmérica EconomíaPhilissa CramerZev Stub
Patrick GatharaSharon WrobelM A HossainRon KampeasTommy Walker
Warren J. BlumenfeldTatjana PihlarBen KnightMelissa ParkeNorimasa TaharaJeremy Sharon
Brad GlossermanTamer NafarFadi Amun In Partnership With ShomrimJeffrey SachsDeborah DananMatthew BarakatMonir GhaediAdil Bhat
|
 |
Bruce GilQuartz |
Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to crown any winners in the...
Despite pressure from the county’s biggest companies to get workers back in the office, the rise of hybrid and remote work has led to record-high...
El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when prescribed to treat...
The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.Read more...
Denmark is the latest in a series of countries that President-elect Donald Trump has threatened with tariffs — joining a list that includes the 26...
Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The medications, which belong to...
A Silicon Valley software engineer is leveraging her technological expertise to help patients use AI to fight back against health insurance claim...
El Lilly’s (LLY) blockbuster weight-loss drug Zepbound is now eligible for Medicare coverage. The news could significantly expand access to the...
The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s inauguration fund.Read...
Outgoing U.S. Federal Trade Commission (FTC) Chair Lina Khan said Tuesday that she hopes her successor in the incoming Trump administration will...
Google’s (GOOGL) anti-aging company Calico released disappointing trial results of its first ever drug.Read more...
You can learn a lot about a country’s healthcare system just by looking at how often people go to the doctor. This figure can tell you about the...
The Louisiana Department of Health has confirmed the death of the first person to contract a severe case of H5N1 bird flu in the U.S.Read more...
Disney (DIS) announced on Monday that it will be merging its Hulu Live TV business with FuboTV (FUBO). The deal will allow Disney to continue...
Over the past few years the health insurance industry has experienced a series of major mergers and acquisitions, further consolidating power into...
After a year packed with food recalls, 2025 is kicking off with yet another one — a broccoli recall over listeria concerns.Read more...
Pharmaceutical companies are raising the price of over 250 brand drugs this year.Read more...
The new year has brought another round of updates to federal hospital price-transparency rules.Read more...
Obesity is a major global health crisis, especially in the United States, but newer weight-loss drugs like Eli Lilly’s (LLY) Zepbound could offer...
Genetic analysis of H5N1 bird flu viruses from a severely ill patient in Louisiana revealed multiple mutations that may enhance the virus’s ability...
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the...
Novo Nordisk (NVO) released mixed clinical-trial results for its potential Ozempic successor on Friday, leaving Wall Street disappointed.Read more...
Bryan Johnson, the tech entrepreneur and millionaire who became famous for infusing his son’s plasma into his blood in an effort to prolong his...
For many people, the holidays mean large family dinners with filling sides, sweet treats, and festive drinks — all things for which weight-loss...
Popular weight-loss drugs like Wegovy and Zepbound are boosting the use of healthcare in the U.S., leading to an uptick in patients getting...
President-elect Donald Trump answered a number of questions regarding his healthcare agenda during a press conference Monday at his Mar-a-Lago...
Robert F. Kennedy Jr., President-elect Donald Trump’s choice to lead the U.S. Department of Health and Human Services, has shed more light on his...
Contestants on Netflix’s (NFLX) hit dating reality TV show “Love is Blind” must be classified as employees, the National Labor Relations Board...
Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound available on telehealth...
Disney (DIS) has no plans to sell its traditional broadcast and cable networks, setting itself apart from competitors who are actively considering...
Amazon (AMZN) is shutting down Freevee, its free streaming service, as part of a broader effort to trim costs and streamline its video division....
Amazon (AMZN) has been steadily expanding into healthcare, and now it’s setting its sights on telehealth companies like Hims & Hers (HIMS) and...
Disney’s streaming business continues to shine, turning a profit for the second quarter in a row.Read more...
Disney’s search for the next leader of the House of Mouse is heating up, as a deadline to name a successor to outgoing Disney CEO Bob Iger has...
23andMe (ME), the company that popularized at-home DNA tests, announced on Tuesday that its sales took a hit during its most recent quarter. The...
Costco (COST) recalled nearly 80,000 pounds of its store-brand butter products last month because they were missing a legally-required allergy...
Disney (DIS), one of the oldest and most beloved entertainment brands in the world, is set to report its fiscal fourth-quarter earnings on Thursday...
A growing number of subscribers to video streaming services such as Netflix (NFLX) and Hulu (DIS) are pausing their subscriptions with plans to...
A growing number of subscribers to video streaming services such as Netflix (NFLX) and Hulu (DIS) are pausing their subscriptions with plans to...
Obesity rates have been steadily rising around the world for decades. Globally, obesity among adults has more than doubled since 1990, reaching 1...
The U.S. Food and Drug Administration (FDA) announced today that it is proposing a new rule to stop the use of an ingredient in popular over-the-...
It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as...
The movie theater industry is staging a comeback. A strong summer box office is paving the way for billions of dollars in planned investments for...
People around the world watched a whopping 94 billion hours of Netflix (NFLX) during the first half of the year. According to the streaming...
The psychology-based digital healthcare platform Noom announced this week that it’s now offering off-brand weight loss drugs starting at $149. Roche...
Eli Lilly (LLY) said on Tuesday that its experimental weekly insulin, efsitora, worked just as well as daily doses for patients with type 1...
Roche stock slid Monday morning after a conference poster highlighted data regarding the side effects patients experienced during an early-stage...
BioAge Labs, a biopharmaceutical startup focused on obesity drugs and an Eli Lilly (LLY) collaborator, filed for an initial public offering on...
Cancer cases and deaths among men worldwide are expected to nearly double, according a new study published Monday in Cancer — a scientific...
login
who are we?
contact us
qosheapp
